FindTrial
Sign In

Identification of a suitable milk-derived product, the consumption of which could prevent vitamin B12 deficiency (IMPROVIT)

Long term uptake study of 3 ug of Hydroxo Vitamin B12 and Cyano Vitamin B12 in Indians adults (IMPROVIT- PART II)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/06/008811
Enrollment
54
Registered
2017-06-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Department of Biotechnology New Delhi India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Vegetarians with low plasma vitamin B12 in Indian participants

Exclusion criteria

Exclusion criteria: Non vegetarians, cancer and the participants consuming vitamin B12 pills and the drugs known to influence vitamin B12 absorption

Design outcomes

Primary

MeasureTime frame
Reduction in homocysteine due to hydroxocobalamin intakeTimepoint: Baseline and every week till eight weeks—

Secondary

MeasureTime frame
Better uptake due to hydroxocobalamin, Increase in holoTC and reduction in HomocysteineTimepoint: Baseline and every week till eight weeks—

Countries

India

Contacts

Public ContactDr Sadanand S Naik

Deenanath Mangeshkar Hospital, Pune, Maharashtra, India

sadu_naik@rediffmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026